Publication | Open Access

N4-Phenyl modifications of N2-(2-hydroxyl)ethyl-6-(pyrrolidin-1-yl)-1,3,5-triazine-2,4-diamines enhance glucocerebrosidase inhibition by small molecules with potential as chemical chaperones for Gaucher disease

Medicinal ChemistryGaucher DiseaseBiochemistryNatural SciencesMedicineN4-phenyl ModificationsGlycobiologyChemical ChaperonesChemical BiologyPharmacologyGlycosylation